Tyrosine hydroxylase (TH) is phosphorylated at four sites in situ and in vivo, and the protein kinases that phosphorylate three of these sites (Ser', Ser"9, Ser4>) have been identified. In intact cells, the phosphorylation of the fourth site (Ser31) is increased in response to phorbol esters or nerve growth factor (NGF). Here 
(Ser31) is increased in response to phorbol esters or nerve growth factor (NGF). Here Activation of catecholaminergic tissues increases the activity of tyrosine hydroxylase (TH), the initial and rate-limiting enzyme in catecholamine biosynthesis (1) . The increase in TH activity is associated with an increase in its phosphorylation, which is thought to mediate the activation (2) . TH is phosphorylated in situ at Ser8, Ser'9, Ser31, and Seri4 (3) , and the phosphorylation of Ser'9, Ser3', and Ser' is regulated by neuronal activity in intact mammalian catecholaminergic tissues (4, 5) .
In vitro, Ser'9 and Ser4O are substrates for Ca2+/calmodulin-dependent protein kinase II (CaM-PKII), and Ser40 is also a substrate for cAMP-dependent protein kinase (PKA) and protein kinase C (PKC) (6) (7) (8) (9) A physiological role for TH-Ser31 kinase activity seems likely in that Ser3' phosphorylation is regulated by neuronal activity in vivo in dopaminergic nerve terminals in the brain (4) and in perfused adrenal glands (5) . Ser31 was only recently identified as a phosphorylation site (3) , and the amino acid sequences surrounding Ser3' (rat, EAVTS31PRF; bovine and human, EAIMS31PRF) offered few clues regarding candidate protein kinases. Unsuccessful candidates include CaM-PKII, PKA, and PKC, and several well-described (8) as well as several recently characterized (4) protein kinases. In the present study, ERK1 and ERK2, members of a family of serine/threonine protein kinases (10) whose activity requires and is regulated by the concomitant phosphorylation of tyrosine and threonine residues on the kinase (10) (11) (12) (13) (14) (15) tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. phate/1.5 mM EGTA/1 mM dithiothreitol/0.1 mM Na3VO4, pH 7.3) containing 1 mM benzamidine and 10 ,ug of leupeptin per ml. The samples were sonicated and centrifuged, and the supernatants were applied to an HR5/5 Mono Q column (Pharmacia) and eluted with a NaCl gradient (19, 20) . Soluble extracts (20) (19) . Reactions (30°C, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] min, 25 p1) were initiated by adding MgATP. 32P incorporation into myelin basic protein (MBP) or TH24-3 was measured after spotting on Whatman P81 paper (20) . Reactions using purified TH were terminated by adding Laemmli sample buffer and heating. After SDS/PAGE, 32p incorporation was measured by scintillation counting of excised TH bands.
Regulation of TH Phosphorylation and ERK Activity in Situ.
PC12 cultures (12-well plates) were rinsed and preincubated (60-90 min, 37°C) in incubation solution containing 32P; (0.5-1 mCi/ml; 1 mCi = 37 MBq). Cells were incubated with test substances (or vehicle) and solubilized for SDS/PAGE (3) . The 32P-labeled TH band was excised and digested with trypsin, and site-specific phosphorylation was quantitated by in-line radiochemical detection of 32P-labeled phosphopeptides separated by reversed-phase HPLC (3, 5) .
In experiments comparing TH-Ser31 phosphorylation and ERK activity, cells were seeded in 12-well plates (incubated with 32P;) and in 6-well plates (incubated without 32P;). After treatment with test substances, the cells were scraped, triturated, and sonicated in ice-cold column buffer containing leupeptin and benzamidine (in lieu of the SDS solution). Ser31 phosphorylation was assayed in supernatants from 32p_ labeled cells after addition of concentrated Laemmli sample buffer, and MPB kinase activity was assayed in aliquots of the supernatants from unlabeled cells.
Ser3l Phosphorylation and TH Activity in Vitro. Purified TH (1 AM TH subunit) was incubated at 30°C for 30 min with -1 ,M catalytic subunit of PKA, ERK1, or ERK2 in column buffer with 10 ,M leupeptin and 50 ,g of bovine serum albumin per ml, 10 mM MgCl2, and 0.1 mM ATP. [y-32P]ATP (=20,000 cpm/pmol) was added for determining the stoichiometry of 32p incorporation. 32p incorporation was determined as above, and the site specificity was determined by reversed-phase HPLC after tryptic digestion of the 32P-TH in gel slices (3) .
TH activity (21) and TH protein (52) were determined as described (5 
RESULTS
Phosphorylation of TH-Ser3' by ERK1 and ERK2 in Vitro. Mono Q chromatography of extracts from control and EGFtreated Swiss 3T3 cells gave three EGF-stimulated peaks of TH-phosphorylating activity, which were eluted at 50, 90, and 150 mM NaCl (Fig. 1A) . The activity in the last two peaks (14, 15) , in Swiss 3T3 cell extracts (18) (19) (20) . The site specificity of TH phosphorylation by the three peaks revealed a TH-Ser31 kinase activity in the second and third peaks but not in the first peak (which produced Ser4 phosphorylation). Kinase activity toward TH24-33 coincided with the latter two peaks of MBP kinase activity (Fig. 1C) . Phosphorylation of TH-Ser3' in Intact PC12 Cells. Treatment of PC12 cells with NGF or phorbol ester selectively increases TH-Ser3l phosphorylation (3). Additional compounds were tested to maximize Ser31 phosphorylation and, by inference, endogenous Ser3t kinase activity. Bradykinin, muscarine, and ATP increased 32p incorporation into -Ser3' (Table 1) . Ser4l phosphorylation was also increased by ATP, acting presumably via a metabolite at adenosine receptors.
This effect of ATP was inhibited by 100 ,uM theophylline, an adenosine receptor antagonist. Thapsigargin and t-Bu2BHQ (which mobilize Ca2+j from inositol trisphosphate-sensitive pools) but not caffeine (which acts upon different calcium pools) also increased Ser31 phosphorylation. NGF and bradykinin were selected for further study.
Identification of TH-Ser3' Kinase Activity in PC12 Cells.
Mono Q chromatography of extracts from NGF-or bradykinin-treated PC12 cells separated two peaks of MBP kinase activity (Fig. 2 A and B) as well as two corresponding peaks ofTH24-33 kinase activity (Fig. 2 C and D) . The peaks of MBP kinase activity from extracts oftreated PC12 cells correspond to ERK2 and ERK1, respectively, in order of elution from Mono Q (10, 18) . Moreover, the TH24-33 and MBP kinase activities in each peak comigrated on Superose 12, and the resulting fractions each phosphorylated Ser31 in purified TH (data not shown). Correlation Between ERK Activity and Ser3' Phosphorylation in Situ. Phosphorylation of both tyrosine and threonine residues is required for ERK activity (10-15, 19, 22) . NGF treatment of PC12 cells increases the phosphotyrosine content of a 44-kDa and a 42-kDa polypeptide band (23, 24) , representing ERK1 and ERK2, respectively (10) . In the present study, we observed an increase in [32P]phosphotyrosine (25) associated with a 44-kDa and a 42-kDa band in response to either NGF or bradykinin (data not shown). Hence, we tested tyrosine kinase inhibitors [lavendustin A, tyrphostin, methyl 2,5-dihydroxycinnamate, 2-hydroxy-5-(2,5-dihydroxybenzyl)aminobenzoic acid, genistein; GIBCO] for effects on agonist-stimulated phosphorylation of TH-Ser3l in PC12 cells. Of these, genistein inhibited Ser3l phosphorylation selectively, without influencing Ser '9 and/or Ser' phosphorylation. Genistein produced a concentration-dependent (10-360 ,uM; 2-to 15-min preincubation) inhibition (up to 80%) of bradykinin-stimulated Ser31 phosphorylation but had little or no effect on TH phosphorylation in samples treated with NGF. To determine whether the changes in TH-Ser3' phosphorylation were paralleled by changes in ERK activity, matched unlabeled and 32P-labeled cells were absence of genistein. The increase in Ser31 phosphorylation produced by either NGF or bradykinin was associated with an increase in ERK activity (Fig. 3) . Moreover, the inhibition by genistein of bradykinin-stimulated Ser31 phosphorylation was associated with an inhibition of ERK activity. By contrast, genistein had little effect on NGF-stimulated Ser3l phosphorylation or on ERK activity (Fig. 3) . Smaller effects of NGF (produced by lower concentrations or shorter treatments) were similarly unaffected by genistein.
Genistein also inhibited the increases in Ser3" phosphorylation produced by BaCl2, PBt2, and muscarine (Table 2) . Neither the CaM-PKII-mediated (26) (27) (28) (Table 3) . However, the increase in TH activity produced by ERK1 was much smaller than that produced by PKA. Phosphorylation by PKA decreased the inhibition of TH activity produced by dopamine, whereas the sensitivity of the ERK1-activated enzyme to dopamine was relatively unchanged. DISCUSSION Ser3' in TH was shown to be a substrate for ERK1 and ERK2 in vitro. The activity of the ERKs toward Ser3' in vitro was produced by treatment of Swiss 3T3 cells with EGF ( Fig. 1) , treatment of PC12 cells with NGF or bradykinin (Fig. 2) ERK1 and ERK2 belong to a family of serine/threonine protein kinases whose activity requires and is regulated by the concomitant phosphorylation of tyrosine and threonine residues in the kinase (10, 13) . ERK activity toward in vitro substrates such as MAP, MBP, and S6 kinase II is increased by treatment of diverse cells with a variety of extracellular messengers, including NGF (11, 14, 15) . When the NGF-and phorbol ester-sensitive phosphorylation site in TH was initially identified as Ser31 (-EAVTS31PRF-) (3), a requirement for proline on the carboxyl side of a serine/threonine phosphorylation site had been described for two protein kinases (29) , yeast p34cdc2/CDC28 and a PC12 enzyme recently identified as a mammalian cdc2 gene product (30) . [The latter enzyme phosphorylates TH in vitro, but at Ser8 as opposed to Ser3' (30) .] Phosphorylation of MBP by MAP kinase (ERK2) was shown to occur at Thr9 (31) , which is immediately N-terminal to a proline residue, and further studies have suggested that a proline two positions N-terminal to the site [i.e., PX(S/T)P] is also important for substrate recognition (32, 33 The early sequelae responsible for the NGF-stimulated increases in Ser31 phosphorylation are less clear. The highaffinity NGF receptor has been identified as the trkB protooncogene product, and NGF treatment of PC12 cells increases its tyrosine phosphorylation (41) (42) (43) (44) (45) . Although this establishes a distinction from the G protein-linked receptors for the other extracellular signals, subsequent biochemical sequelae in the PC12 cells include tyrosine phosphorylation of phospholipase C-y, increased diacylglycerol levels, and activation of PKC (44) (45) (46) (47) . As such, these data support a potential involvement of PKC activity in NGF's effects on Ser31 phosphorylation. However, down-regulation of PKC fails to block either the Ser31 phosphorylation (48) or the MAP kinase activation (36) produced by NGF. Such data would not be contradictory if NGF were to activate a pool of PKC that was compartmentally isolated from the cascade, in which case the convergence ofthe signaling pathways leading to ERK activation/Ser91 phosphorylation could occur downstream of PKC activation. One potential locus is the MAP kinase activator (18) , which is activated by bradykinin and NGF (19) ; however, convergence at the kinases themselves could occur as well.
TH activity is increased directly by Ser`0 phosphorylation in vitro whereas Ser19 phosphorylation is thought to be permissive to activation by 14-3-3 (previously referred to as "activator protein") (see ref. 5 and references therein). The phosphorylation of Ser31 in vitro has not been demonstrated previously, but treatment ofPC12 cells with either bradykinin or NGF has been shown to increase TH activity measured subsequently in vitro (49) (50) (51) . In one study (51), a 40-50% increase in TH activity was associated with an increase specifically in Ser3' phosphorylation. In the present study, TH activity was increased 20-40% after Ser31 phosphorylation; however, it is difficult to assign a physiological significance to this effect in light of the 2-to 15-fold increases in TH activity produced by PKA. Alternatively, the functional consequences of ERK activation/TH phosphorylation may result indirectly by modulating effects produced by another signaling pathway whose activity also reflects increased levels of secretory activity (hence a need for higher rates of tyrosine hydroxylation). For example, Ser3' phosphorylation could affect TH activity by altering the effects of cAMP/PKA/Ser40 phosphorylation or Ca2+/CaM-PKII/ Ser19 phosphorylation.
